Century Therapeutics, Inc. Profile Avatar - Palmy Investing

Century Therapeutics, Inc.

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent s…

Biotechnology
US, Philadelphia [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Century Therapeutics, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of IPSC's Analysis
CIK: 1850119 CUSIP: 15673T100 ISIN: US15673T1007 LEI: - UEI: -
Secondary Listings
IPSC has no secondary listings inside our databases.